Literature DB >> 35601719

A Rare Pediatric Case of Cefixime Induced Toxic Epidermal Necrolysis.

Tirin Babu1, George Mathew Panachiyil1, Prajwala Hassan Vasudev2, Mandyam Dhati Ravi2.   

Abstract

Cefixime is a third-generation cephalosporin that has been used for the treatment of a wide range of infections in children and adults. The incidence of cefixime induced toxic epidermal necrolysis (TEN) is less than 2% in adults, but it is infrequent among pediatric patients. We report a rare case of cefixime induced TEN in a 7-year-old boy. In this case, the child presented with symptoms of TEN after 2 days of administration of cefixime. This case highlights the need to select structurally different antibiotics in case of antibiotic-induced severe cutaneous adverse reaction (SCAR) to avoid recurrence of SCAR. Furthermore, concluded that irrational use of antibiotics could be disastrous as it can result in TEN as the incidence of antibiotics induced TEN ranges from 29% to 42%.
© The Author(s) 2021.

Entities:  

Keywords:  cefixime; cephalosporin; severe cutaneous adverse reaction; toxic epidermal necrolysis

Year:  2021        PMID: 35601719      PMCID: PMC9117772          DOI: 10.1177/00185787211016332

Source DB:  PubMed          Journal:  Hosp Pharm        ISSN: 0018-5787


  2 in total

1.  Causes and treatment outcomes of Stevens-Johnson syndrome and toxic epidermal necrolysis in 82 adult patients.

Authors:  Hye-In Kim; Shin-Woo Kim; Ga-Young Park; Eu-Gene Kwon; Hyo-Hoon Kim; Ju-Young Jeong; Hyun-Ha Chang; Jong-Myung Lee; Neung-Su Kim
Journal:  Korean J Intern Med       Date:  2012-05-31       Impact factor: 2.884

2.  Retrospective analysis of stevens-johnson syndrome and toxic epidermal necrolysis over a period of 10 years.

Authors:  Abarna Devi Sanmarkan; Tukaram Sori; Devinder Mohan Thappa; T J Jaisankar
Journal:  Indian J Dermatol       Date:  2011-01       Impact factor: 1.494

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.